Overview A Long-term Trial of OPC-34712 in Patients With Schizophrenia Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary To investigate the safety and efficacy of long-term administration of OPC-34712 in patients with schizophrenia. Phase: Phase 3 Details Lead Sponsor: Otsuka Pharmaceutical Co., Ltd.